Orthotopic liver of multivisceral transplantation as treatment of metastatic neuroendocrine tumors

Liver Transplantation

Volumn 13, Issue 3, 2007, Pages 327-333

  Olausson, Michael ^a   Friman, Styrbjörn ^a   Herienius, Gustaf ^a   Cahlin, Christian ^a   Nilsson, Ola ^a   Jansson, Svante ^b   Wängberg, Bo ^b   Ahlman, Håkan ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CYCLOSPORIN A; DACLIZUMAB; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; LUTETIUM 177; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OCTREOTATE[3 TYROSINE DOTA LUTETIUM 117]; OCTREOTIDE; PREDNISONE; RAPAMYCIN; SOMATOSTATIN DERIVATIVE; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BENIGN TUMOR; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOID; CARCINOID SYNDROME; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; GASTRINOMA; GLUCAGONOMA; GRAFT SURVIVAL; HEMIHEPATECTOMY; HEPATIC ARTERY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER METASTASIS; LIVER TRANSPLANTATION; MALE; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURVIVAL TIME; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; DUODENUM; FEMALE; HUMANS; IMMUNOSUPPRESSION; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROENDOCRINE TUMORS; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33947354249     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21056     Document Type: Article

References (20)

1. Florman S, Toure B, Kim, L, Gondolesi G, Roayaie S, Krieger N, et al. Liver transplantation for neuroendocrine tumors. J Gastrointest Surg 2004:8:208-212.
2. Rosado, B. Gores GJ. Liver transplantation for neuroendocrine tumors progress and uncertainty. Liver Transpl 2004;10:712-713.
3. Schweizer RT, Alsina AE, Rosson R, Bartus SA. Liver transplantation for metastatic neuroendocrine tumors. Transplant Proc 1993;25:1973.
4. Olausson M, Friman, S, Cahlin C, Nilsson O, Jansson S, Wängberg B, et al. Indications and results of liver transplantation on patients with neuroendocrine tumors World J Surg 2002;26:998-1004.
5. Bechstein WO, Neuhaus P. Liver transplantation for hepatic metastases of neuroendocrine tumors. Ann N Y Acad Sci 1994;733:507-514.
6. Lang H, Oldhafer KJ, Weimann A, Schlitt HJ, Scheumann GF, Flemming P, et al. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 1997;225:347-354
7. Le Treut W, Delpero JR, Dousset B, Cherqui D, Segol P, Mantion G, et al. Result, of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg 1997;225:355-364.
8. Sutcliffe, P, Maguire D, Ramage J, Rela M, Heaton N. Management of neuroendocrine liver metastases. Ann J Surg 2004; 187:39-46
9. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation 1998;66:1307-1312.
10. van Vilsteren FGI, Baskin-Bey ES, Nagorney DM, Sanderson SO, Kremers WK, Rosen CB, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers defining selection criteria to improve survival. Liver Transpl 2006:12:448-456
11. Alessiani M, Tzakis, A, Todo S, Demetris F, Fong JJ, Starzl TF. Assessment of 5-year experience with abdominal cluster transplantation. J Am Coll Surg 1995:180:1-9
12. Stridsberg M, Öberg K, Li Q, Engström U, Lundqvist G. Measurements of chromogranin A. chromogranin B (secretogranin I). chromogranin C (secretogranin II) and pancreostatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 1995;144:49-59
13. Moertel CG, Johnson CM, Mc Kusick MA, Martin JK Jr, Nagorney DM, Kvols LK. et al. The managenament of patients with advanced carcinoid tumours and islet cell carcinomas. Ann Intern Med 1994;120:302-309,
14. Pelosi G, Bresaola E, Bognia G, Pasini F, Rodella S, Castelli R, et al. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy. Hum Pathol 1996;27:1124-1134,
15. Scholzen T, Gerdes J. The K1-67 protein: from the known and the unknown. J Cell Physiol 2000;182:311-322.
16. Rosenau J, Bahr MJ, von Wasielewski R, Mengel M, Schmidt HH, Nashan B, et al. K167, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 2002:73:386-394.
17. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-896
18. Ahlman H, Nilsson O, Olausson M. Interventional treatment of the carcinoid syndrome. Neuroendocrinology 2004:80(suppl 1):67-73.
19. Wängberg B, Westberg G, Tylén U, Tisell LE, Jansson S, Nilsson O. et al. Survival of patients with disseminated midgut carcinoids after aggressive tumor reduction. World J Surg 1996; 20:892-899.
20. Johanson V, Tisell LE, Olbe L, Wängberg B, Nilsson O, Ahlman H. Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin. Br J Cancer 1999;80:1259-1261.